Ventyx Biosciences Statistics
Total Valuation
VTYX has a market cap or net worth of $147.08 million. The enterprise value is -$116.71 million.
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025, after market close.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VTYX has 70.71 million shares outstanding. The number of shares has increased by 13.07% in one year.
| Current Share Class | 70.71M |
| Shares Outstanding | 70.71M |
| Shares Change (YoY) | +13.07% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 4.59% |
| Owned by Institutions (%) | 58.69% |
| Float | 49.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.53 |
| P/TBV Ratio | 0.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.52, with a Debt / Equity ratio of 0.04.
| Current Ratio | 23.52 |
| Quick Ratio | 22.37 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.24% and return on invested capital (ROIC) is -35.50%.
| Return on Equity (ROE) | -54.24% |
| Return on Assets (ROA) | -33.39% |
| Return on Capital (ROIC) | -35.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.91M |
| Employee Count | 80 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.58% in the last 52 weeks. The beta is 0.55, so VTYX's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +5.58% |
| 50-Day Moving Average | 2.26 |
| 200-Day Moving Average | 2.82 |
| Relative Strength Index (RSI) | 45.64 |
| Average Volume (20 Days) | 1,957,855 |
Short Selling Information
The latest short interest is 9.60 million, so 13.57% of the outstanding shares have been sold short.
| Short Interest | 9.60M |
| Short Previous Month | 8.63M |
| Short % of Shares Out | 13.57% |
| Short % of Float | 19.51% |
| Short Ratio (days to cover) | 5.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -166.38M |
| Pretax Income | -171.30M |
| Net Income | -152.52M |
| EBITDA | -166.12M |
| EBIT | -166.38M |
| Earnings Per Share (EPS) | -$2.33 |
Full Income StatementBalance Sheet
The company has $274.83 million in cash and $11.04 million in debt, giving a net cash position of $263.79 million or $3.73 per share.
| Cash & Cash Equivalents | 274.83M |
| Total Debt | 11.04M |
| Net Cash | 263.79M |
| Net Cash Per Share | $3.73 |
| Equity (Book Value) | 278.77M |
| Book Value Per Share | 3.94 |
| Working Capital | 277.11M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$159.28 million and capital expenditures -$446,000, giving a free cash flow of -$159.73 million.
| Operating Cash Flow | -159.28M |
| Capital Expenditures | -446,000 |
| Free Cash Flow | -159.73M |
| FCF Per Share | -$2.26 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |